Literature DB >> 3294590

Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo.

A M Fichtinger-Schepman, P H Lohman, F Berends, J Reedijk, A T van Oosterom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3294590

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


× No keyword cloud information.
  6 in total

1.  Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.

Authors:  Kriste A Lewis; Kia K Lilly; Evelyn A Reynolds; William P Sullivan; Scott H Kaufmann; William A Cliby
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

2.  Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).

Authors:  W I Sundquist; S J Lippard; B D Stollar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Intercalation of proflavine and a platinum derivative of proflavine into double-helical Poly(A).

Authors:  C Ciatto; M L D'Amico; G Natile; F Secco; M Venturini
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

4.  Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.

Authors:  M Alaoui-Jamali; B B Loubaba; S Robyn; H Tapiero; G Batist
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.

Authors:  Debashree Mukherjea; Asmita Dhukhwa; Amit Sapra; Priyanka Bhandari; Katlyn Woolford; Jacob Franke; Vickram Ramkumar; Leonard Rybak
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-09-29       Impact factor: 4.481

6.  Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.

Authors:  Toshifumi Kishimoto; Yuko Yoshikawa; Kenichi Yoshikawa; Seiji Komeda
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.